Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FX006 vs placebo and immediate-release triamcinolone for pain in knee osteoarthritis
2014-005329-11Phase 3Completed
- Sponsor
- Flexion Therapeutics
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of triamcinolone acetonide in knee osteoarthritis (OA) (3 arms), sponsored by Flexion Therapeutics. Started Jan 2015; status: completed.
02
Drugs
triamcinolone acetonide
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2014-005329-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005329-11.